Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL4782344 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
GPR52 in Human [GtoPdb: 108] [UniProtKB: Q9Y2T5] | ||||||||
GtoPdb | - | - | 6.2 | pIC50 | 630 | nM | IC50 | J Med Chem (2021) 64: 941-957 [PMID:33185430] |
GPR52/G-protein coupled receptor 52 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4105791] [GtoPdb: 108] [UniProtKB: P0C5J4] | ||||||||
ChEMBL | In-vivo antagonist activity at GPR52 in HdhQ140 mouse model with GPR52 knockdown assessed as decrease in mHTT levels | F | 6.2 | pIC50 | 630 | nM | IC50 | J Med Chem (2021) 64: 938-940 [PMID:33443413] |
GPR52/Probable G-protein coupled receptor 52 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3297639] [GtoPdb: 108] [UniProtKB: Q9Y2T5] | ||||||||
ChEMBL | Antagonist activity at GPR52 (unknown origin) expressed in HEK293 cells assessed as inhibition of WO459-induced cAMP accumulation preincubated for 15 mins followed by WO459 addition and measured after 30 mins by LANCE Ultra cAMP kit based microplate reader analysis | F | 6.06 | pIC50 | 880 | nM | IC50 | J Med Chem (2021) 64: 941-957 [PMID:33185430] |
GtoPdb | - | - | 6.2 | pIC50 | 630 | nM | IC50 | J Med Chem (2021) 64: 941-957 [PMID:33185430] |
ChEMBL | Inhibition of GPR52 (unknown origin) | B | 6.2 | pIC50 | 630 | nM | IC50 | J Med Chem (2022) 65: 15993-16032 [PMID:36490325] |
ChEMBL data shown on this page come from version 35:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]